Literature DB >> 22965209

Concurrent validity of the Bayley-III and the Peabody Developmental Motor Scale-2.

Barbara H Connolly1, Nancy Oberg McClune, Roberta Gatlin.   

Abstract

PURPOSE: To determine concurrent validity of the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) and the Peabody Developmental Motor Scales, Second Edition (PDMS-2).
METHOD: Tests were administered to 48 children with corrected age ranging from 29 days to 26 months. Concurrent validity between age-equivalent (AE) scores and standard scores was assessed for 4 age groups.
RESULTS: Moderate to very high correlation for all groups was found between the Bayley-III composite scores and the PDMS-2 Total Motor quotient scores. High correlations were found between the Bayley-III composite scores and the PDMS-2 Gross and Fine Motor quotients (12-26 months); high correlations were found between the Bayley-III and the PDMS-2 Gross Motor quotient (6-12 months) and moderate correlations were found for younger age groups. High concurrent validity for AE scores was found only above 18 months.
CONCLUSIONS: The study supports the substitution of the Bayley-III for the PDMS-2 for standard scores or AE scores for children aged 19 to 26 months and for standard scores for children birth to 18 months.

Entities:  

Mesh:

Year:  2012        PMID: 22965209     DOI: 10.1097/PEP.0b013e318267c5cf

Source DB:  PubMed          Journal:  Pediatr Phys Ther        ISSN: 0898-5669            Impact factor:   3.049


  15 in total

1.  Motor development skills of 1- to 4-year-old Iranian children with early treated phenylketonuria.

Authors:  Sepideh Nazi; Farzaneh Rohani; Firoozeh Sajedi; Akbar Biglarian; Arya Setoodeh
Journal:  JIMD Rep       Date:  2013-08-06

2.  The Early Motor Questionnaire (EMQ): a parental report measure of early motor development.

Authors:  Klaus Libertus; Rebecca J Landa
Journal:  Infant Behav Dev       Date:  2013-10-18

3.  Concurrent validity of the TIMP and the Bayley III scales at 6 weeks corrected age.

Authors:  Suzann K Campbell; Laura Zawacki; Kristin M Rankin; Joseph C Yoder; Nicole Shapiro; Zhuoying Li; Rosemary White-Traut
Journal:  Pediatr Phys Ther       Date:  2013       Impact factor: 3.049

4.  Motor developmental status of moderately low birth weight preterm infants.

Authors:  Azita Tavasoli; Faranak Aliabadi; Rooholah Eftekhari
Journal:  Iran J Pediatr       Date:  2014-08-15       Impact factor: 0.364

5.  Autism and intellectual disability associated with mitochondrial disease and hyperlactacidemia.

Authors:  José Guevara-Campos; Lucía González-Guevara; Omar Cauli
Journal:  Int J Mol Sci       Date:  2015-02-11       Impact factor: 5.923

6.  Surgical, medical and developmental outcomes in patients with Down syndrome and cataracts.

Authors:  Stephanie L Santoro; Dema Atoum; Robert B Hufnagel; William W Motley
Journal:  SAGE Open Med       Date:  2017-06-19

Review 7.  What's missing in autism spectrum disorder motor assessments?

Authors:  Rujuta B Wilson; James T McCracken; Nicole J Rinehart; Shafali S Jeste
Journal:  J Neurodev Disord       Date:  2018-12-13       Impact factor: 4.025

8.  Comparison of Bayley-2 and Bayley-3 scores at 18 months in term infants following neonatal encephalopathy and therapeutic hypothermia.

Authors:  Sally Jary; Andrew Whitelaw; Lars Walløe; Marianne Thoresen
Journal:  Dev Med Child Neurol       Date:  2013-08-09       Impact factor: 5.449

9.  GAME (Goals - Activity - Motor Enrichment): protocol of a single blind randomised controlled trial of motor training, parent education and environmental enrichment for infants at high risk of cerebral palsy.

Authors:  Catherine Morgan; Iona Novak; Russell C Dale; Andrea Guzzetta; Nadia Badawi
Journal:  BMC Neurol       Date:  2014-10-07       Impact factor: 2.474

10.  Use of the Physical Abilities and Mobility Scale (PAMS) in Children Receiving Inpatient Rehabilitation for Spinal Cord Related Paralysis.

Authors:  Cynthia Salorio; Kelsey Rogers; Erin Neuland; Julie Cagney; Cristina Sadowsky
Journal:  Dev Neurorehabil       Date:  2021-08-06       Impact factor: 2.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.